Skip to content

Water Oxygenation and Brain Activity

Water Oxygenation and Brain Activity: A Magnetoencephalographic (MEG) Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02688452
Enrollment
40
Registered
2016-02-23
Start date
2012-12-31
Completion date
2017-07-01
Last updated
2017-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle Damage

Keywords

strenuous exercise, muscle soreness

Brief summary

The primary purpose of this interventional, placebo controlled, crossover, double blind, basic science exploratory study is to investigate whether there is a difference in brain electrophysiological oscillatory activity in healthy adults before and after oral consumption of water containing very small bubbles of oxygen (electrokinetically modified water).

Interventions

DIETARY_SUPPLEMENTControl Unmodified Placebo Water
DIETARY_SUPPLEMENTElectrokinetically modified water (EMW)

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Men or women of any ethnic background; * living in New York tri-state area; * fluent in English; * normal or corrected to normal vision and hearing; * willing to complete all study procedures; and * capable of giving written informed consent.

Exclusion criteria

* A history of gross brain abnormalities such as stroke, severe ventriculomegaly or severe periventricular white matter abnormalities; * a history of serious psychiatric or neurological disorders, including psychosis or major depression, alcohol or drug abuse, brain injury, seizure disorder, brain tumor, etc.; * taking psychoactive medications, including antipsychotics, anxiolytics and antidepressants, or cognitive enhancers such as cholinesterase inhibitors; * presence of contraindications for MEG or MRI recording, including any of the following: cardiac pacemaker, intracranial clips, metal implants, or external clips within 10 mm of the head, metal in eyes, claustrophobia, obesity and/or any other reason leading to difficulty staying in the MEG or MRI for up to one hour.

Design outcomes

Primary

MeasureTime frameDescription
Changes in spectral properties measured before and after drinking the test products using Magnetoencephalography (MEG) measurements1 WeekMagnetic fields will be recorded using a 275-channel whole-head MEG system
Changes in localization of spontaneous brain activity measured before and after drinking the test products using Magnetoencephalography (MEG) measurements1 WeekMagnetic fields will be recorded using a 275-channel whole-head MEG system

Secondary

MeasureTime frame
Self reported changes in behavioral state before and after drinking test product1 Week

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026